Product Title: Ocular Surface Disease: Cornea, Conjunctiva and Tear Film (Original PDF from Publisher)
Format:
PDF,
Overview (Details, Topics and Speakers):
[]
Edward J Holland MD (Author), Mark J Mannis MD FACS (Author), W. Barry Lee MD FACS (Author)
Ocular Surface Disease: Cornea, Conjunctiva and Tear Film incorporates current research and the latest management strategies as well as classification systems and treatment paradigms for all forms of ocular surface disease. This is the first comprehensive resource that helps you to meet ocular surface disease challenges effectively using today’s best medical and surgical approaches.
- Get the complete, evidence-based guidance you need to provide optimal care for your patients with ocular surface disease.
- Implement the latest drug treatments and surgical interventions to provide better outcomes with fewer complications.
- Hone and expand your surgical skills by watching videos of leading experts performing advanced procedures including ocular surface transplantation techniques; amniotic membrane transplantation; pterygium surgery; lamellar keratoplasty (DALK) in ocular surface disease; and keratoprosthesis surgery.
- Visualize how to proceed by reviewing detailed, full-color images and consulting new classification systems and treatment paradigms for mild to severe forms of ocular surface disease.
- Take it with you anywhere! Access the full text, downloadable image library, video clips, and more online at expertconsult.com.
Product Details
- Hardcover: 472 pages
- Publisher: Saunders; 1 Har/Psc edition (May 31, 2013)
- Language: English
- ISBN-10: 1455728764
- ISBN-13: 978-1455728763
- ISBN-13: 9781455728763
- eText ISBN: 9781455756230
Delivery Method
the Ocular Surface Disease: Cornea, Conjunctiva and Tear Film (Original PDF from Publisher) course/book will be provided for customer as download link. download link has NO Expiry and can be used anytime.
Contact Us
contact us to our email at support@med-cme.com or fill in the form below:
Reviews
There are no reviews yet.